A new study reports depressed people who responded to ketamine found their activity increased during earlier parts of the day. Researchers suggest clock gene machinery may be linked to the type of depression that responds to ketamine treatment.
A new study implicates serotonin 2c receptors with metabolic side effects caused by a common class of antipsychotic medications.
White matter integrity appears to be reduced in people with major depressive disorders, a new Scientific Reports study reveals.
Minocycline, a broad-spectrum tetracycline antibiotic, has shown promise in the treatment of depression. Researchers say the antibiotic could help reduce brain inflammation associated with some cases of major depressive disorder. A small study conducted by researchers at Deakin University found those treated with Minocycline reported improved quality of life, reduced anxiety symptoms and a better global impression of their depression.
Researchers have discovered a link between specific neural circuits to distinct behavioral symptoms of depression. The study, published in Cell, reports altering the networks helped to improve symptoms such as social withdrawal and helplessness.
Exposing depressed adolescents to positive and negative words elicited different effects in specific brain regions depending on the sex of the subject, a new Frontiers in Psychiatry study reports.
Researchers are utilizing neuroimaging data to identify brain patterns and predict depression with the help of machine learning.
According to researchers, people with major depressive disorder who embark on twice weekly yoga classes and who also practice at home reported a reduction in their symptoms.
Depression may allow people to abandon achievable goals, a new study reports.
According to researchers, a yogic breathing technique could help those with major depressive disorder who did not fully respond to antidepressant therapies.
A new study reveals neuroimaging may prove useful in revealing patients with depression who may respond well to psychotherapy.
According to a new study, experimentally increasing the activity of a subclass of nerve cells that produce GABA has an antidepressant effect in mice.
